Completed
This public workshop explored challenges and opportunities in manufacturing regenerative medicine therapeutics as the field evolves to accommodate higher volume production and increased capacity for delivering regenerative medicine treatments to patients. Presentations and discussions considered how new developments in areas such as closed systems, decentralized manufacturing, and automation can affect manufacturing cell- or gene-based therapies.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People